$NASDAQ:ORMP

Oramed Pharmaceuticals Intrinsic Value – Oramed Pharmaceuticals Stock Closes at $2.73, Consensus Estimates for Next Quarter Remain Positive

Trending News ☀️ Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc. has recently closed at $2.73, a decrease of -1.44% from the prior session's [...]

By |May 13, 2023|Categories: Biotechnology, Intrinsic Value|Tags: , , |0 Comments

Oramed Pharmaceuticals Stock Fair Value – 2023: Oramed Pharmaceuticals CEO Purchases $201,000 in Stock in Insider Buying.

Trending News 🌥️ In recent news, Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc. CEO, Nadav Kidron, has purchased $201,000 in stock through insider [...]

By |March 28, 2023|Categories: Biotechnology, Uncategorized|Tags: , , |0 Comments

Oramed Pharmaceuticals Stock Intrinsic Value – Oramed Pharmaceuticals’ P3 Type 2 Diabetes Trial Fails to Meet Expectations

Trending News 🌧️ Oramed Pharmaceuticals Stock Intrinsic Value - Oramed Pharmaceuticals ($NASDAQ:ORMP) recently announced the results of its Phase 3 [...]

By |January 30, 2023|Categories: Biotechnology, Future Forecasts, Intrinsic Value|Tags: , , |0 Comments

Shareholders of Oramed Pharmaceuticals Express Gratitude for Ongoing Support and Commitment to Innovative Treatments

Trending News ☀️ Oramed Pharmaceuticals Stock Fair Value – Dear Shareholders of Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc., Oramed Pharmaceuticals Inc. is [...]

By |December 28, 2022|Categories: Intrinsic Value|Tags: , , |0 Comments
Go to Top